AI Article Synopsis

Article Abstract

Background: Familial hypercholesterolemia (FH) due to a founder variant in Apolipoprotein B (ApoB) is reported in 12% of the Pennsylvania Amish community. By studying a cohort of ApoB heterozygotes and homozygotes, we aimed to characterize the biochemical and cardiac imaging features in children and young adults with a common genetic background and similar lifestyle.

Methods: We employed advanced lipid profile testing, carotid intima media thickness (CIMT), pulse wave velocity (PWV), and peripheral artery tonometry (PAT) to assess atherosclerosis in a cohort of Amish ApoB heterozygotes (n = 13), homozygotes (n = 3), and their unaffected, age-matched siblings (n = 9). ApoB homozygotes were not included in statistical comparisons.

Results: LDL cholesterol (LDL-C) was significantly elevated among ApoB heterozygotes compared to sibling controls, though several ApoB heterozygotes had LDL-C levels in the normal range. LDL particles (LDL-P), small, dense LDL particles, and ApoB were also significantly elevated among subjects with ApoB. Despite these differences in serum lipids and particles, CIMT and PWV were not significantly different between ApoB heterozygotes and controls in age-adjusted analysis.

Conclusions: We provide a detailed description of the serum lipids, atherosclerotic plaque burden, vascular stiffness, and endothelial function among children and young adults with FH due to heterozygous ApoB. Fasting LDL-C was lower than what is seen with other forms of FH, and even normal in several ApoB heterozygotes, emphasizing the importance of cascade genetic testing among related individuals for diagnosis. We found increased number of LDL particles among ApoB heterozygotes but an absence of detectable atherosclerosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928591PMC
http://dx.doi.org/10.1186/s12872-022-02539-3DOI Listing

Publication Analysis

Top Keywords

apob heterozygotes
28
apob
12
ldl particles
12
familial hypercholesterolemia
8
children young
8
young adults
8
particles apob
8
serum lipids
8
heterozygotes
7
clinical characterization
4

Similar Publications

Article Synopsis
  • Familial hypercholesterolemia (FH) is a genetic disorder that causes high LDL cholesterol levels, increasing the risk of early cardiovascular diseases due to atherosclerosis.
  • A study involving 17 patients treated between 2019 and 2024 found the most common genetic mutation affecting LDL levels, with significant responses to alirocumab treatment among those with single mutations.
  • Patients with double mutations showed much less effectiveness in reducing LDL cholesterol, highlighting a need for different treatment strategies for those cases.
View Article and Find Full Text PDF

Polygenic risk of high LDL cholesterol and ischemic heart disease in the general population.

Atherosclerosis

October 2024

Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address:

Background And Aims: We tested the association of polygenic risk scores (PRS) for low-density lipoprotein cholesterol (LDL-C) and coronary artery disease (CAD) with LDL-C and risk of ischemic heart disease (IHD) in the Danish general population.

Methods: We included a total of 21,485 individuals from the Copenhagen General Population Study and Copenhagen City Heart Study. For everyone, LDL-PRS and CAD-PRS were calculated, each based on >400,000 variants.

View Article and Find Full Text PDF

Abetalipoproteinemia (ABL) is a rare disease characterized by extremely low apolipoprotein B (apoB)-containing lipoprotein levels, dietary fat, and fat-soluble vitamin malabsorption, leading to gastrointestinal, neuromuscular, and ophthalmological symptoms. We herein report a case of ABL with novel compound heterozygous mutations in the microsomal triglyceride transfer protein gene (c.1686_1687del [p.

View Article and Find Full Text PDF

Familial hypobetalipoproteinemia (FHBL) 1 is a rare genetic disorder with an autosomal codominant mode of inheritance and is caused by defects in the apolipoprotein (apo) B (APOB) gene that disable lipoprotein formation. ApoB proteins are required for the formation of very low-density lipoproteins (VLDLs), chylomicrons, and their metabolites. VLDLs transport cholesterol and triglycerides from the liver to the peripheral tissues, whereas chylomicrons transport absorbed lipids and fat-soluble vitamins from the intestine.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!